[Epidural non-Hodgkin's lymphoma presenting as a spinal cord compression]

Ann Pathol. 2001 Apr;21(2):123-8.
[Article in French]

Abstract

Objective and methods: epidural localization is a rare presenting sign of non Hodgkin's lymphoma. In this study, we describe the clinical, histological and immunohistochemical data in 13 cases (9 men and 4 women) of non-Hodgkin's lymphoma with epidural involvement.

Results: the median age was 63 years (range 36-76 years). Clinically, most patients complained of back pain (median duration, 3.4 months) followed by acute neurological deterioration. In 10 out of 13 tumors, a thoracic localization was observed and a decompressive laminectomy was performed in all cases. Histology and immunohistochemistry showed all tumors to be B-cell lymphomas which were classified as: lymphocytic lymphoma (3 cases), prolymphocytic lymphoma (1 case), follicular lymphoma (2 cases), diffuse large cell lymphoma (6 cases) and AIDS associated Burkitt lymphoma (1 case). Post-operative staging revealed bone and/or paravertebral involvement in 11 cases and disseminated disease in 5 cases. Median survival following complementary therapy, radiotherapy and chemotherapy in most cases, was 20 months.

Conclusion: histological features of epidural lymphomas are similar to other extranodal lymphomas and their prognosis is better than other epidural neoplasms, especially when the tumor is localized.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy
  • Epidural Neoplasms / diagnosis*
  • Epidural Neoplasms / pathology
  • Epidural Neoplasms / surgery
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / surgery
  • Lymphoma, Follicular / diagnosis
  • Lymphoma, Large B-Cell, Diffuse / diagnosis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Radiotherapy
  • Spinal Cord Compression / diagnosis*
  • Spinal Cord Compression / etiology
  • Survival Rate

Substances

  • Antineoplastic Agents